The biggest issue has been less skarn and more intrusion than they hoped for (expected). Its been obvious for a while that the results have been pretty patchy in between the high grade zones.
Given the drill results I think KK's current focus of presenting the high grade Hualilan component as a low cost, high return, stand alone project is the right strategy.
Not a perfect outcome but then again - few things ever are.
- Forums
- ASX - By Stock
- Ann: Hualilan Gold Project Scoping Study
The biggest issue has been less skarn and more intrusion than...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CEL (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.38M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $103.6K | 2.182M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 475611 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 700000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 475611 | 0.048 |
3 | 440441 | 0.047 |
6 | 881111 | 0.046 |
11 | 971178 | 0.045 |
2 | 850000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 600000 | 1 |
0.050 | 450000 | 2 |
0.051 | 380000 | 2 |
0.052 | 320000 | 1 |
0.053 | 460000 | 2 |
Last trade - 15.46pm 10/10/2024 (20 minute delay) ? |
Featured News
CEL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online